title: Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.
abstract: The mechanisms of endogenous cannabinoid biosynthesis are not completely understood. We hypothesized that anandamide could be recycled by the cell to form new endocannabinoid molecules and released into the extracellular space. We determined that new endocannabinoids derived from exogenous anandamide or arachidonic acid were synthesized and released from RBL-2H3 cells in response to ionomycin. Treatment of RBL-2H3 cells with nystatin and progesterone, agents that disrupt organization of lipid raft/caveolae, resulted in the attenuation of anandamide and 2-arachidonyl glycerol synthesis and/or release in response to stimulation with ionomycin suggesting a role for these membrane microdomains in endocannabinoid biosynthesis. Furthermore, anandamide synthesis may be independent of N-acyl phosphatidylethanolamine phospholipase D as expression of the enzyme was not detected in RBL-2H3 cells. We also established that extracellular calcium is necessary for endocannabinoid biosynthesis because release of intracellular calcium stores alone does not promote endocannabinoid biosynthesis. Next, we examined the role of calcium as a 'switch' to activate the synthesis of anandamide and simultaneously reduce uptake. Indeed, [(3)H] anandamide uptake was reduced in the presence of calcium. Our findings suggest a mechanism indicative of calcium-modulated activation of anandamide synthesis and simultaneous termination of uptake.
authors.affiliation: Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47904, USA.
authors.forename: Ekaterina A
authors.initials: EA
authors.lastname: Placzek
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Okamoto
authors.forename: Natsuo
authors.initials: N
authors.lastname: Ueda
authors.forename: Eric L
authors.initials: EL
authors.lastname: Barker
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000096:biosynthesis* / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D021941:Caveolae / Q000187:drug effects / Q000378:metabolism; D002461:Cell Line, Transformed; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004305:Dose-Response Relationship, Drug; D063388:Endocannabinoids; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005989:Glycerides / Q000096:biosynthesis* / Q000494:pharmacology; D015759:Ionomycin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D007783:Lactones / Q000378:metabolism; D009761:Nystatin / Q000494:pharmacology; D010739:Phospholipase D / Q000378:metabolism; D053284:Polyunsaturated Alkamides / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology; D051381:Rats; D019284:Thapsigargin / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium / Q000378:metabolism
chemical_list: D001095:Arachidonic Acids; D063388:Endocannabinoids; D004791:Enzyme Inhibitors; D005989:Glycerides; D007476:Ionophores; D007783:Lactones; D053284:Polyunsaturated Alkamides; D011372:Progestins; C406526:SKM 4-45-1; D014316:Tritium; D009761:Nystatin; D011374:Progesterone; D015759:Ionomycin; D019284:Thapsigargin; C094503:glyceryl 2-arachidonate; D010739:Phospholipase D; D002118:Calcium; C078814:anandamide
references.citation: Nature. 1999 Jul 29;400(6743):452-7
references.pmid: 10440374
references.citation: J Biol Chem. 2008 Apr 4;283(14):9341-9
references.pmid: 18227059
references.citation: J Membr Biol. 2004 Jul 15;200(2):93-104
references.pmid: 15520907
references.citation: J Biol Chem. 1996 Nov 15;271(46):29427-35
references.pmid: 8910609
references.citation: J Biol Chem. 1978 Sep 10;253(17):5892-4
references.pmid: 28319
references.citation: Prog Neurobiol. 2001 Apr;63(5):569-611
references.pmid: 11164622
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):319-32
references.pmid: 12052046
references.citation: Arch Gen Psychiatry. 2000 Jun;57(6):547-52
references.pmid: 10839332
references.citation: Biochemistry. 2006 Apr 18;45(15):4720-6
references.pmid: 16605240
references.citation: Expert Opin Investig Drugs. 2003 Jan;12(1):39-49
references.pmid: 12517253
references.citation: J Biol Chem. 2006 Sep 8;281(36):26465-72
references.pmid: 16818490
references.citation: J Neurochem. 2006 Nov;99(4):1164-75
references.pmid: 17010161
references.citation: J Biol Chem. 2004 Oct 1;279(40):41991-7
references.pmid: 15292270
references.citation: Life Sci. 2002 Mar 15;70(17):1963-77
references.pmid: 12148689
references.citation: Anal Biochem. 2005 Apr 1;339(1):113-20
references.pmid: 15766717
references.citation: J Pharmacol Exp Ther. 2000 Apr;293(1):289-95
references.pmid: 10734181
references.citation: Science. 1997 Aug 22;277(5329):1094-7
references.pmid: 9262477
references.citation: Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):173-87
references.pmid: 9716939
references.citation: Biochim Biophys Acta. 2000 Nov 23;1508(1-2):182-95
references.pmid: 11090825
references.citation: J Cell Biol. 2003 Nov 10;163(3):463-8
references.pmid: 14610053
references.citation: Cell Calcium. 2007 Aug;42(2):173-82
references.pmid: 17602740
references.citation: J Neurosci. 1997 Feb 15;17(4):1217-25
references.pmid: 9006967
references.citation: Biochemistry. 2002 Feb 12;41(6):2075-88
references.pmid: 11827555
references.citation: J Biol Chem. 2008 Jun 20;283(25):17333-40
references.pmid: 18430726
references.citation: Br J Pharmacol. 2000 Jan;129(2):227-30
references.pmid: 10694225
references.citation: BMJ. 2001 Jul 7;323(7303):16-21
references.pmid: 11440936
references.citation: Neuropharmacology. 2005 Jun;48(8):1072-8
references.pmid: 15910883
references.citation: FEBS Lett. 1998 Jan 23;422(1):69-73
references.pmid: 9475172
references.citation: Science. 2007 Jun 8;316(5830):1494-7
references.pmid: 17556587
references.citation: Curr Opin Chem Biol. 2003 Aug;7(4):469-75
references.pmid: 12941421
references.citation: Nature. 1993 Sep 2;365(6441):61-5
references.pmid: 7689702
references.citation: J Biol Chem. 2004 Feb 13;279(7):5298-305
references.pmid: 14634025
references.citation: Nat Rev Neurosci. 2003 Nov;4(11):873-84
references.pmid: 14595399
references.citation: Br J Pharmacol. 2008 Jan;153(2):380-9
references.pmid: 17965731
references.citation: Annu Rev Neurosci. 2006;29:37-76
references.pmid: 16776579
references.citation: Nat Rev Cancer. 2003 Oct;3(10):745-55
references.pmid: 14570037
references.citation: Biochem J. 1998 Apr 1;331 ( Pt 1):15-9
references.pmid: 9512456
references.citation: J Neurosci. 1993 Mar;13(3):1280-91
references.pmid: 7680068
references.citation: Biochim Biophys Acta. 2001 May 31;1532(1-2):121-7
references.pmid: 11420181
references.citation: Biochem Pharmacol. 1993 Sep 1;46(5):791-6
references.pmid: 8373432
references.citation: Cell. 1992 Feb 21;68(4):673-82
references.pmid: 1739974
references.citation: Eur J Immunol. 1981 Apr;11(4):317-23
references.pmid: 6166481
references.citation: Pharmacol Rev. 2002 Sep;54(3):431-67
references.pmid: 12223531
references.citation: J Med Chem. 2005 Aug 11;48(16):5059-87
references.pmid: 16078824
references.citation: Mol Pharmacol. 2008 Jul;74(1):101-8
references.pmid: 18436710
references.citation: Nature. 1990 Aug 9;346(6284):561-4
references.pmid: 2165569
references.citation: Biochim Biophys Acta. 1998 Jun 15;1392(2-3):153-75
references.pmid: 9630590